Cosmetic cross-reference

Aloe Barbadensis Leaf

CAS 8001-97-6

Aloe Barbadensis Leaf (CAS 8001-97-6) is a pharmaceutical compound with 0 bioactivity targets and 880 adverse event associations.

SOURCE NLM DailyMed

Label records

SOURCE EMBL-EBI ChEMBL

Bioactivity

SOURCE DrugCentral

Adverse signals

880

SOURCE IUPHAR/BPS

PubMed IDs

SOURCE NLM DailyMed 20346FBA692B

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Aloe Barbadensis Leaf

CAS Number

8001-97-6

UNII

ZY81Z83H0X

Source Match

DailyMed Label Data

Synonyms and normalized names

ALOE BARBADENSIS LEAF EXTRACTALOE BARBADENSIS LEAF JUICEALOE VERA LEAF EXTRACTALOE VERA LEAFALOE BARBADENSIS LEAF POWDERALOE BARBADENSIS LEAF JUICE POWDER

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE NLM DailyMed 2 label rows

Drug Label Active Ingredients

Active ingredient and active moiety rows from source drug product labels.

Product	Ingredient	Active Moiety	Effective
AKOLKOL TOENAIL FUNGUS TREATMENT	ALOE BARBADENSIS LEAF ZY81Z83H0X	ALOE BARBADENSIS LEAF	20260506
Nail Repairs Patches	ALOE BARBADENSIS LEAF ZY81Z83H0X	ALOE BARBADENSIS LEAF	20260506

SOURCE NLM RxNorm 9 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

Name	RxCUI	Type	Source
ALOE BARBADENSIS LEAF EXTRACT	1306128	SU	MTHSPL
ALOE BARBADENSIS LEAF JUICE	1306128	SU	MTHSPL
ALOE VERA LEAF EXTRACT	1306128	SU	MTHSPL
ALOE BARBADENSIS LEAF	1306128	SU	MTHSPL
ALOE VERA LEAF	1306128	SU	MTHSPL
Aloe Vera Leaf	1306128	SU	MTHSPL
aloe vera leaf	1306128	SU	MTHSPL
ALOE BARBADENSIS LEAF POWDER	2697730	SU	MTHSPL
ALOE BARBADENSIS LEAF JUICE POWDER	2697730	SU	MTHSPL

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Aloe Barbadensis Leaf used for in pharmaceutical contexts?

Aloe Barbadensis Leaf (CAS 8001-97-6) appears in DailyMed active-ingredient label rows, including AKOLKOL TOENAIL FUNGUS TREATMENT, Nail Repairs Patches.

What are the known adverse events for Aloe Barbadensis Leaf?

Aloe Barbadensis Leaf has 880 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Anxiety, Brain fog, Cognitive disorder, Disturbance in attention, Diverticulitis. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Aloe Barbadensis Leaf also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for ALOE BARBADENSIS LEAF with EU status "permitted".

What clinical phase is Aloe Barbadensis Leaf in?

No phase 1-4 clinical development badge is rendered for Aloe Barbadensis Leaf because the matched compound identifier rows do not contain a max-phase value.